GENEVA, Oct. 1 -- SPITFIRE PHARMA LLC filed a patent application (US2026/019189) for “GLP-1R AND GCGR IN THE TREATMENT OF ALCOHOL-ASSOCIATED LIVER DISORDERS IN SUBJECTS WITH OBESITY OR OVERWEIGHT HUMAN BEINGS”. With publication no. WO/2026/193447, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....